199 related articles for article (PubMed ID: 24368535)
21. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
[TBL] [Abstract][Full Text] [Related]
22. Lu-177 labelled peptide treatment for radioiodine refractory differentiated thyroid carcinoma.
Elboğa U; Özkaya M; Sayiner ZA; Çelen YZ
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26957032
[TBL] [Abstract][Full Text] [Related]
23. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
24. Bilateral axillary and infrahilar nodal metastases in follicular variant of papillary thyroid carcinoma (transformed into poorly differentiated subtype) in the setting of elevated thyroglobulin and negative radioiodine scintigraphy.
Basu S
J Cancer Res Ther; 2016; 12(1):423-4. PubMed ID: 27072275
[No Abstract] [Full Text] [Related]
25. Macrofollicular variant of papillary carcinoma: a potential thyroid FNA pitfall.
Chung D; Ghossein RA; Lin O
Diagn Cytopathol; 2007 Sep; 35(9):560-4. PubMed ID: 17703452
[TBL] [Abstract][Full Text] [Related]
26. Three cases of macrofollicular variant of papillary thyroid carcinoma.
Emad R; Maha A; Kfoury HK; Al-Sheikh AM; Zaidi SN
Ann Saudi Med; 2011; 31(6):644-7. PubMed ID: 22048513
[TBL] [Abstract][Full Text] [Related]
27. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
28. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
[TBL] [Abstract][Full Text] [Related]
29. Cribriform-morular variant of papillary thyroid carcinoma: characteristic histologic feature of adenomatous polyposis. A case report.
Gronnier C; Donatini G; Leteurtre E; Do Cao C; Carnaille B
Ann Endocrinol (Paris); 2012 Jun; 73(3):213-5. PubMed ID: 22387099
[TBL] [Abstract][Full Text] [Related]
30. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
31. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
32. The treatment of thyroid malignancies with radioiodine [proceedings].
Cottino F
J Nucl Med Allied Sci; 1977; 21(1-2):55-6. PubMed ID: 915550
[No Abstract] [Full Text] [Related]
33. A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.
Ben Ghachem T; Yeddes I; Meddeb I; Bahloul A; Mhiri A; Slim I; Ben Slimene MF
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):655-660. PubMed ID: 27225282
[TBL] [Abstract][Full Text] [Related]
34. Low postoperative nonstimulated thyroglobulin as a criterion for the indication of low radioiodine activity in patients with papillary thyroid cancer of intermediate risk 'with higher risk features'.
Rosario PW; Mourão GF; Calsolari MR
Clin Endocrinol (Oxf); 2016 Sep; 85(3):453-8. PubMed ID: 26801644
[TBL] [Abstract][Full Text] [Related]
35. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma.
Licht K; Kroegel C; Katenkamp K; Freesmeyer M
Clin Nucl Med; 2016 Apr; 41(4):336-7. PubMed ID: 26571446
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic Transformation in Mandibular Metastases of Follicular Variant of Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.
Ambelil M; Sultana S; Roy S; Gonzalez MM
Ann Clin Lab Sci; 2016 Sep; 46(5):552-6. PubMed ID: 27650625
[TBL] [Abstract][Full Text] [Related]
37. BRAF mutation in papillary thyroid carcinoma: predictive value for long-term prognosis and radioiodine sensitivity.
Zoghlami A; Roussel F; Sabourin JC; Kuhn JM; Marie JP; Dehesdin D; Choussy O
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Feb; 131(1):7-13. PubMed ID: 23845288
[TBL] [Abstract][Full Text] [Related]
38. Thyroglobulin flare response after radioiodine ablation in 2 patients with differentiated thyroid cancer.
Tsang JF; Levin DP; Leslie WD
Clin Nucl Med; 2015 May; 40(5):421-2. PubMed ID: 25546193
[TBL] [Abstract][Full Text] [Related]
39. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
40. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
